GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • Could virus make the leap from birds to people? Saturday, 30 May 2015 | 12:02 PM ET
    Lacey Kurth, a research associate, works with avian influenza test samples during testing in the real-time analytical diagnostics lab at the Iowa State University College of Veterinary Medicine in Ames, Iowa.

    There have only been four flu pandemics since the start of the 20th century, yet concerns are widening about the potential for a new outbreak.

  • Chicago May 29- Bristol-Myers Squibb Co's drug, Opdivo, improved survival in a trial of patients with the most common form of lung cancer, but it did not work in patients who tested negative for a specific protein in their tumors, leading to a nearly 7 percent sell-off in the company's shares on Friday. The Bristol drug was approved by U.S. regulators in December to...

  • New class of drugs shows promise for cancer fight Friday, 29 May 2015 | 2:18 PM ET

    A study sheds light on why the new medicines seem to work for some cancers and not others, NYT reports.

  • OPDIVO BENEFIT SIGNIFICANTLY HIGHER IN LUNG CANCER TUMORS WITH HIGH LEVEL OF PD-L1 PROTEIN-STUDY.

  • Chicago May 29- Bristol-Myers Squibb Co's drug, Opdivo, improved survival for patients with the most common form of lung cancer, nearly doubling survival for those with high levels of a specific protein in their tumors compared with chemotherapy, according to clinical trial results presented on Friday. The Bristol drug was approved by U.S. regulators in...

  • BRISTOL'S OPDIVO CUTS DEATH RISK 27 PCT IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER-STUDY.

  • BRISTOL-MYERS SQUIBB'S OPDIVO EXTENDS SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER-STUDY.

  • WASHINGTON, May 28- The U.S. Food and Drug Administration on Thursday approved the first drug to treat a rare, progressive lung disease that mainly affects women of childbearing age. The drug, Rapamune, known chemically as sirolimus, is made by Pfizer Inc and is designed to treat lymphangioleiomyomatosis, a disease that causes lung damage and affects only two to...

  • WASHINGTON, May 28- U.S. antitrust regulators have settled a long-running fight with Cephalon, now owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit over the sleep disorder drug Provigil, the Federal Trade Commission said on Thursday. Cephalon had been accused by the FTC of illegally protecting its monopoly on Provigil by...

  • May 27- Drug developer GlobeImmune Inc said its experimental hepatitis B drug did not reduce infection in patients after 24 weeks of treatment in a mid-stage study, sending the company's shares down as much as 60 percent to a record low. GlobeImmune, which is developing the drug with Gilead Sciences Inc, is among several drugmakers looking to tap the demand for...

  • May 27- GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial. GlobeImmune is developing the drug, GS-4774, with Gilead Sciences Inc.. Companies developing hepatitis B drugs include Arrowhead Research Corp, Canada's Tekmira Pharmaceuticals Corp and Isis...

  • GlobeImmune, Gilead Hep B drug fails in mid-stage study Wednesday, 27 May 2015 | 6:50 AM ET

    May 27- GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial. However, the drug was found to reduce HBsAg, an antigen that indicates the strength of hepatitis B infection, after 48 weeks, the company said on Wednesday. GlobeImmune is developing the drug, GS-4774, with...

  • COPENHAGEN, May 26- Bavarian Nordic is hot property after striking two big vaccine deals but the small Danish company is not for sale, despite a wave of consolidation in the healthcare industry, its chief told Reuters. Boosting the immune system is now a top priority for cancer drug companies such as Bristol-Myers, Merck, Roche and AstraZeneca, fuelling renewed...

  • *OIE warns U.S. bird flu viruses could spread to Mexico. PARIS, May 26- An epidemic of bird flu that has devastated U.S. poultry flocks this year is likely to be under control within four months as the United States steps up measures to contain the virus, the head of the World Organisation for Animal Health said. However, there is a high risk that strains of the virus will...

  • May 21- Biotech firm Bluebird Bio Inc said its experimental gene therapy continued to exhibit a positive effect in an ongoing early-stage study of patients with rare types of blood disorders. The product, LentiGlobin, is being tested in patients with beta-thalassemia major and those with severe sickle cell disease, two hereditary conditions.

  • May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United...

  • NEW YORK, May 20- A U.S. group is trying to block patents in five countries for Gilead Sciences Inc's costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people access to cheaper generic versions. In Argentina, Brazil, China, Russia and Ukraine, challenges have been filed against Gilead's patents or patent applications, the New York- based...

  • May 19- The U.S. Food and Drug Administration approved a longer-acting version of Johnson& Johnson's schizophrenia treatment, developed by the company's Janssen Pharmaceuticals unit. The FDA approved the drug, Invega Trinza, to be administered just four times a year, the longest dosing interval available for the treatment of the neurological disorder,...

  • INSIGHT-Is nicotine all bad? Tuesday, 19 May 2015 | 5:59 AM ET

    LONDON, May 19- Since he ditched Marlboro Lights five years ago, Daniel's fix is fruit-flavoured nicotine gum that comes in neat, pop-out strips. He gets through 12 to 15 pieces a day and says he has "packets of the stuff" stashed all over. Psychologists and tobacco-addiction specialists, including some in world-leading laboratories in Britain, think it's now time...

  • May 15- The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca, Johnson& Johnson and Eli Lilly in partnership with Boehringer Ingleheim may cause dangerously high levels of blood acids that could require hospitalization. The FDA said its Adverse Event Reporting System database...